RUNX3 and acute myeloid leukemia: CLQ and MFQ are two recently identified anti-leukemia agents, to find out the effects of CLQ and MFQ on gene expression associated with their anti-cancer activity, DNA microarray analyses were performed in OCI-AML2, a typical acute myelogenous leukemia cell line.